Clinical trial
Efficacy Study of the Effect of Budesonide on Emphysema
NCT00232674 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00232674 |
|---|---|
| Title | Efficacy Study of the Effect of Budesonide on Emphysema |
| Official title | The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT). |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Pulmicort (budesonide) Turbuhaler |
| Enrollment | 240 |
| Start date | Jul 1, 1999 |
| Completion | Feb 1, 2004 |
| First posted | Oct 5, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: